U.S., March 11 -- ClinicalTrials.gov registry received information related to the study (NCT07461259) titled 'Safety and Feasibility of TWIICE Rise - Phase 2' on April 22, 2024.
Brief Summary: The aim of this study is to assess the safety and the feasibility of two versions of TWIICE Rise for exoskeleton-assisted ambulation in patients with a spinal cord injury.
This study is done in two phases:
The first phase evaluates the safety and feasibility of TWIICE Rise 0.0 with 5 patients over 6 sessions in clinic. The second phase is being conducted with TWIICE Rise 1.0. This version has potentially improved functionalities based on feedback from Phase 1. Safety and feasibility will be assessed with 10 patients over 10 sessions in different se...